•
Jun 30, 2017

AcelRx Q2 2017 Earnings Report

Total Revenue
$2.66M
Previous year: $4.53M
-41.3%
EPS
-$5.8
Previous year: -$4.8
+20.8%
Gross Profit
-$884K
Previous year: $1.56M
-156.8%
Cash and Equivalents
$62.1M
Previous year: $97.8M
-36.5%
Free Cash Flow
-$10.2M
Total Assets
$78.2M
Previous year: $114M
-31.2%

AcelRx

AcelRx